120 related articles for article (PubMed ID: 25835533)
1. Glycosylation of KSHV encoded vGPCR functions in its signaling and tumorigenicity.
Wu H; Liu L; Xiao J; Chi M; Qu Y; Feng H
Viruses; 2015 Mar; 7(4):1627-41. PubMed ID: 25835533
[TBL] [Abstract][Full Text] [Related]
2. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
Sodhi A; Montaner S; Gutkind JS
FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
[TBL] [Abstract][Full Text] [Related]
3. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma.
Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA
PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440
[TBL] [Abstract][Full Text] [Related]
4. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
Martin D; Nguyen Q; Molinolo A; Gutkind JS
Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
[TBL] [Abstract][Full Text] [Related]
6. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.
Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS
Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat.
Guo HG; Pati S; Sadowska M; Charurat M; Reitz M
J Virol; 2004 Sep; 78(17):9336-42. PubMed ID: 15308728
[TBL] [Abstract][Full Text] [Related]
8. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
9. The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells.
Cannon ML; Cesarman E
Oncogene; 2004 Jan; 23(2):514-23. PubMed ID: 14724579
[TBL] [Abstract][Full Text] [Related]
10. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.
Montaner S; Sodhi A; Molinolo A; Bugge TH; Sawai ET; He Y; Li Y; Ray PE; Gutkind JS
Cancer Cell; 2003 Jan; 3(1):23-36. PubMed ID: 12559173
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tumorigenicity of fibroblasts transformed with human herpesvirus 8 chemokine receptor vGPCR by successive passage in nude and immunocompetent mice.
Thirunarayanan N; Cifire F; Fichtner I; Posner S; Benga J; Reiterer P; Kremmer E; Kölble K; Lipp M
Oncogene; 2007 Aug; 26(39):5702-12. PubMed ID: 17353903
[TBL] [Abstract][Full Text] [Related]
12. KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma.
Abere B; Schulz TF
Curr Opin Virol; 2016 Oct; 20():11-19. PubMed ID: 27518127
[TBL] [Abstract][Full Text] [Related]
13. Initiation of angiogenic Kaposi's sarcoma lesions.
Hayward GS
Cancer Cell; 2003 Jan; 3(1):1-3. PubMed ID: 12559168
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma virally encoded, G-protein-coupled receptor: a paradigm for paracrine transformation.
Martin D; Gutkind JS
Methods Enzymol; 2009; 460():125-50. PubMed ID: 19446723
[TBL] [Abstract][Full Text] [Related]
15. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S
Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of T cells by γ2-herpesviral GPCR through the interaction with cellular CXCR4.
Kwon EK; Min CK; Kim Y; Lee JW; Aigerim A; Schmidt S; Nam HJ; Han SK; Kim K; Cha JS; Kim H; Kim S; Cho HS; Choi MS; Cho NH
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):1-11. PubMed ID: 27751885
[TBL] [Abstract][Full Text] [Related]
17. Sulfotyrosines of the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promote tumorigenesis through autocrine activation.
Feng H; Sun Z; Farzan MR; Feng P
J Virol; 2010 Apr; 84(7):3351-61. PubMed ID: 20106924
[TBL] [Abstract][Full Text] [Related]
18. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor.
Sodhi A; Montaner S; Patel V; Gómez-Román JJ; Li Y; Sausville EA; Sawai ET; Gutkind JS
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4821-6. PubMed ID: 15047889
[TBL] [Abstract][Full Text] [Related]
19. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma.
Montaner S
Cell Cycle; 2007 Feb; 6(4):438-43. PubMed ID: 17329974
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase is required for KSHV vGPCR signaling.
He M; Bakken T; Kassimova A; Boshoff C; Philpott N; Cannon ML
Mol Carcinog; 2012 Apr; 51(4):339-51. PubMed ID: 21538577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
